Papillary Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Papillary Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
Clinical trial evaluating ultrasound-guided thermal ablation for papillary thyroid carcinoma is currently recruiting.
-
CLINICAL_TRIALS approval · 2025-01-17Clinical Trial Update: Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Eli Lilly's RET inhibitor selpercatinib (Retevmo) has been approved for marketing to treat cancers driven by RET activation, including non-s…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma
This clinical trial is comparing ultrasound-guided microwave ablation to surgery for low-risk papillary thyroid carcinoma. The study is curr…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC [Phase 2]
Phase 2 trial assessing restoration of I-131 uptake with selpercatinib in RET fusion-positive, radioiodine-refractory thyroid cancer; curren…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma
A clinical trial update describing an upcoming multiomics study on the biology of lymph node metastasis in papillary thyroid carcinoma (not …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma [NA]
A clinical trial evaluating a retro-auricular single-site endoscopic approach for papillary thyroid carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola [NA]
A completed clinical trial assessed the safety of endoscopic thyroidectomy using retro-auricular single-site, transoral, and transareolar ap…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Iodine Status and Characteristics of Papillary Thyroid Cancer
This clinical trial investigates iodine status and characteristics of papillary thyroid carcinoma and is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC
The study compares single-incision gasless endoscopic total thyroidectomy via subclavian access to open surgery for papillary thyroid carcin…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients [NA]
A clinical trial at the Second Affiliated Hospital of Xi'an Jiaotong University is recruiting to evaluate improvements in thyroid tumor surg…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images
A completed clinical trial evaluated predicting cervical lymph node metastasis in papillary thyroid carcinoma using ultrasound and cytologic…
-
FDA approval · 2024-04-10FDA Approved: RETEVMO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for RETEVMO (selpercatinib) from Eli Lilly, expanding its labeled indications for RET fusion–positiv…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) [Phase 2]
A Phase 2 trial evaluating the combination of lenvatinib and pembrolizumab in differentiated thyroid cancers has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating trametinib for increasing tumoral iodine incorporation in patients with recurrent or metastatic thyroid cancer; res…
-
CLINICAL_TRIALS research · 2022-02-18Clinical Trial Update: Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients. [Phase 4]
A Phase 4 trial exploring how a Type 2 Deiodinase gene polymorphism affects treatment of hypothyroidism in thyroid cancer patients post-thyr…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating whether adding selumetinib to radioactive iodine improves outcomes in patients with recurrent or metastatic thyroid…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer [Phase 1, Phase 2]
Clinical trial update for cediranib maleate with or without lenalidomide in thyroid cancer completed; results posted in 2021.
-
FDA approval · 2020-05-08FDA Approved: RETEVMO — Original Application (Eli Lilly and Company)
FDA approved Retevmo (selpercatinib) from Eli Lilly in its original NDA. The approval covers RET fusion-positive non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer [Phase 2]
Phase 2 trial of cabozantinib-s-malate in patients with refractory thyroid cancer has been completed, with results posted in 2018. The study…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer [NA]
This clinical trial update notes the completion of a study evaluating CT-based detection of metastatic lymphadenopathy in papillary thyroid …
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery [Phase 2]
This Phase 2 trial evaluated Sunitinib malate in iodine-refractory thyroid cancers, including differentiated and medullary subtypes. Results…
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma [NA]
This update reports on a clinical trial evaluating detection of BRAF mutation on fine-needle aspiration biopsy samples from papillary thyroi…
-
CLINICAL_TRIALS research · 2017-07-12Clinical Trial Update: Targeted-sequencing of PTC in Different Stages
An exploratory clinical trial update on targeted sequencing of papillary thyroid carcinoma across different stages, sponsored by Shanghai 6t…
-
CLINICAL_TRIALS research · 2017-06-21Clinical Trial Update: Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others
A completed clinical trial update examining how patients with papillary thyroid microcarcinoma and their significant others make treatment d…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study [NA]
Pre-operative nodal staging of thyroid cancer evaluated with USPIO MRI in a preliminary study; results have been posted.